Endocrinology Practice Guidelines

Clinical Practice Guidelines in Endocrinology

What are clinical practice guidelines in endocrinology? A frequently updated repository of essential guidelines for endocrine associations worldwide.

Development of Endocrinology Guidelines

Endocrinology clinical practice guidelines are developed to assist clinicians in providing the best possible care for their patients. These guidelines provide recommendations on the diagnosis and management of endocrine disorders, as well as on the prevention and treatment of endocrine-related conditions.

The Endocrine Society’s Clinical Affairs Core Committee (CACC) is responsible for developing and updating the Society’s clinical practice guidelines. The CACC is a multidisciplinary panel of experts in endocrinology who review the evidence and make recommendations based on their clinical experience and judgment.

The development of clinical practice guidelines requires a rigorous review of the scientific evidence. The first step is to identify all relevant studies through comprehensive literature searches. Next, the studies are critically appraised for their quality and relevance. The evidence is then synthesized and used to generate recommendations.

The Endocrine Society’s clinical practice guidelines are developed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system. This system is a well-established, internationally recognized approach to developing clinical practice guidelines.

The GRADE system takes into account the strength of the evidence, as well as the balance of benefits and harms, and values and preferences. The GRADE system also considers feasibility and resource implications when making recommendations.

Recommendations are made by the CACC and are reviewed and approved by the Society’s Board of Directors. Clinical practice guidelines are updated on a regular basis as new evidence becomes available.

LocationSocietyCurrent versionDownloadCondition
USAAACE2009Download PDFAdrenal incidentaloma
KoreaKES2017Download PDFAdrenal incidentaloma
EuropeESE2016Download PDFAdrenal incidentaloma
FranceFSE2008Download PDFAdrenal incidentaloma
USAES2018Download PDFcongenital adrenal hyperplasia
EuropeESE2016Download PDFcongenital adrenal hyperplasia
EuropeESE2018Download PDFadrenocortical carcinoma (ACC)
EuropeESMO2012Download PDFadrenocortical carcinoma (ACC)
USAES2016Download PDFAdrenal insufficiency
JapanJES2016Download PDFAdrenal insufficiency
EuropeSCCM/ESICM2017Download PDFAdrenal insufficiency
USAES2016Download PDFPrimary hyperaldosteronism
USAES2016Download PDFCushing’s syndrome
EuropeESE2016Download PDFPheochromocytoma and paraganglioma
USAES2014Download PDFPheochromocytoma and paraganglioma
SpainSEEN2021Download PDFPheochromocytoma and paraganglioma
USAADA2021Download PDFDiabetes Mellitus
USAAACE2020Download PDFDiabetes Mellitus
EuropeESC/EASD2019 (cardiovascular disease)Download PDFdiabetes (special patient populations)
USAES2019 (cardiovascular disease)Download PDFdiabetes (special patient populations)
USAES2019 (geriatric patients)Download PDFdiabetes (special patient populations)
EuropeNICE2020 (pregnancy)Download PDFdiabetes (special patient populations)
USAES2013 (pregnancy)Download PDFdiabetes (special patient populations)
USAES2016Download PDFDiabetes technologies
USAAACE2021Download PDFDiabetes technologies
USAATA2015 (adult)Download PDFdifferentiated thyroid cancer
USAATA2015 (pediatric)Download PDFdifferentiated thyroid cancer
USAATA2021Download PDFanaplastic thyroid cancer
EuropeETA2012Download PDFmedullary thyroid cancer
USAATA2015Download PDFmedullary thyroid cancer
EuropeETA2018Download PDFGraves’ hyperthyroidism
EuropeETA2017Download PDFthyroid nodules
USAAACE2016Download PDFthyroid nodules
EuropeETA2018Download PDFamiodarone associated thyroid dysfunction
USAATA2017Download PDFthyroid disease in pregnancy
EuropeETA2012Download PDFhypothyroidism
USAATA2014Download PDFhypothyroidism
USAES2014Download PDFacromegaly
USAPS2021Download PDFacromegaly
USAES2016Download PDFhypopituitarism
USAES2011Download PDFprolactinomas
USAES2011Download PDFadult growth hormone deficiency
USAES2011Download PDFpituitary incidentaloma
EuropeEAU2021Download PDFinfertility in men
USAAUA/ASRM2020Download PDFinfertility in men
USAES2018Download PDFTestosterone replacement therapy
EuropeEAU2018Download PDFTestosterone replacement therapy
USAAUA2018Download PDFTestosterone replacement therapy
Europe/USAEAA/ASA2019Download PDFgynecomastia
EuropeEAA2020Download PDFKlinefelter syndrome
USAES2018Download PDFhirsutism
USAES2017Download PDFFunctional Hypothalamic Amenorrhea
USAES2014Download PDFAndrogen therapy in women
USAES2013Download PDFpolycystic ovary syndrome
USAES2017Download PDFTransgender Medicine
USAAACE2020Download PDFHormones of abuse
EuropeESE2020Download PDFObesity medicine
USAAACE2016Download PDFObesity medicine
USAES2015Download PDFObesity medicine
USAES2020Download PDFosteoporosis
USAUSPSTF2018Download PDFosteoporosis
USAACP2017Download PDFosteoporosis
USANOF2014Download PDFosteoporosis
USAES2012 (osteoporosis in men)Download PDFosteoporosis
EuropeESE2015Download PDFchronic hypoparathyroidism
USAATA2018Download PDFchronic hypoparathyroidism
EuropeEUA2020Download PDFurolithiasis

Fellowship Resources

A collection of resources for endocrinology fellows (books, research, podcasts, question banks etc)
RESOURCES

References

The Endocrine Society’s clinical practice guidelines are freely available online

Kindly Let Us Know If This Was helpful? Thank You!